No Data
Viking Therapeutics, Inc. (VKTX) Increases Yet Falls Behind Market: What Investors Need to Know
What's Next for Viking Therapeutics? Here's How the Company Can Scale Up.
Express News | Viking Therapeutics Shares Spike Higher; Last up 3.4%
Oppenheimer Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $164
Why Viking Therapeutics, Inc. (VKTX) Crashed Last Week
Why Viking Therapeutics Stock Popped, but Novo Nordisk and Hims & Hers Health Dropped Today